| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |